MRI findings in acute idiopathic transverse myelopathy in children

Savvas Andronikou1, Glenda Albuquerque-Jonathan, Jo Wilmshurst

  • 1Department of Paediatric Radiology, Red Cross Children's Hospital, University of Cape Town and School of Child and Adolescent Health, Klipfontein Road, Cape Town, South Africa. docsav@mweb.co.za

Pediatric Radiology
|July 25, 2003
PubMed
Abstract

Insights

Acute idiopathic myelopathy (AIM) in children presents with rapid symptoms and responds well to steroids. Extensive MRI findings in AIM do not predict poor outcomes in pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Neuroimaging
  • Inflammatory Myelopathies

Background:

  • Acute idiopathic myelopathy (AIM) is a rare neurological condition affecting the spinal cord.
  • Understanding the clinical presentation and MRI characteristics is crucial for diagnosis and prognosis.

Observation:

  • Three pediatric cases of AIM were reviewed retrospectively.
  • Clinical data included symptom onset, preceding illnesses, vaccination history, and treatment response.
  • MRI findings focused on T2-weighted hyperintensity and gadolinium enhancement patterns.

Findings:

  • AIM presented with swift symptom onset in all cases.
  • Two patients had no preceding illness or vaccination history.
  • All patients showed rapid symptom resolution with steroid therapy.
  • MRI revealed T2 hyperintensity and patchy enhancement, but extensive cord involvement did not correlate with clinical severity or outcome.

Implications:

  • MRI findings alone, such as diffuse myelopathy, may not be a reliable predictor of poor outcomes in childhood AIM.
  • This study highlights the importance of clinical response to treatment in assessing prognosis for pediatric AIM.